TRUNATURE

Resveratrol Plus 250 mg

D
N+ Score64
Longevity & NAD+Serving: 1 Vegetarian Capsule(s)Type: Other Combinations

Resveratrol Plus 250 mg by TRUNATURE is a Longevity & NAD+ category supplement focusing on a blend of four ingredients, primarily featuring Resveratrol at 250mg, alongside Red Wine extract (50mg), Grape extract (50mg), and Green Tea extract (50mg). This product has an N+ Score of 64, resulting in a 'D' grade, indicating it falls into the average tier. While the label transparency is 100%, our analysis suggests that the Resveratrol dosage, though present, may not reach levels consistently associated with clinical efficacy in all research contexts. The ingredient adequacy and formula completeness scores of 50% and 25% respectively, highlight potential areas for improved formulation. This supplement might be considered by individuals interested in a basic resveratrol-focused product for general antioxidant support.

About This Product

Resveratrol Plus 250 mg by TRUNATURE is a longevity & nad+ supplement containing 4 active ingredients. It has earned an N+ Score of 64/100 (Grade D).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (4 ingredients)

IngredientAmountDose Adequacy
Green Tea extract50.000 mgN/A
Grape extract50.000 mgN/A
Resveratrol250.000 mgN/A
Red Wine extract50.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.